There is increased risk for incident myocardial infarction among adults aged 18 to 64 years with joint exposure to ozone and increased ambient temperature.

The FDA has accepted the New Drug Application for ET-600, an oral solution formulation of desmopressin, for the treatment of central diabetes insipidus.

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

Compared with those with overweight and normal weight, people with obesity were more likely to report financial hardship and food insecurity.

Higher UPF-consumption was linked to worse knee OA outcomes among women, including higher pain scores, worse physical function, and thinner knee cartilage.

There has been an increase in certain cardiometabolic risk factors and a decrease in others among adults in the United States in recent years.

Traditional cardiovascular risk assessment tools underperform among individuals with metabolic dysfunction-associated steatotic liver disease.

There is increased risk for atrial fibrillation in patients with implanted devices exposed to hot outdoor temperatures.

Early abdominal CT may be warranted among patients with unknown or uncertain biochemical screening results for primary aldosteronism.

MASLD rates have decreased, whereas liver fibrosis and cirrhosis rates have increased among US patients with type 2 diabetes since 2017.

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.